Comparative

OMIA group 2293

Phenylketonuria

The chain reaches the human disease phenylketonuria, which Mondo defines as: “A rare inborn error of amino acid metabolism characterized by elevated blood phenylalanine and low levels or absence of phenylalanine hydroxylase enzyme. If not detected early or left untreated, the disorder manifests with mild to severe mental disability.”

The chain

From the animal disease to the drugs. The page shows what each step found and where the chain stopped. It does not say whether the animal is a model of a human disease.

  1. Animal disease

    Reached

    OMIA records it in 1 species entry marked as a defect.

  2. Human disease

    Reached

    1 Mondo disease.

  3. Human gene

    Reached

    1 human gene.

  4. Target evidence

    Reached

    1 Open Targets association, with a best score of 0.89.

  5. Drugs

    Reached

    1 ChEMBL drug, 1 approved. At least one has been tested for this disease.

Natural-model score

How complete and how well supported the chain to each human disease is, out of 100, by stated rules. It does not say that the animal is a validated model of the human disease. How the score works.

phenylketonuria

66.0 out of 100

Part Computed from Points
Target evidence Open Targets score of 0.89 31.0 of 35
Drugs A drug has reached approved for this disease 25.0 of 25
Ortholog No gene of a naturally occurring entry reaches a human gene 0.0 of 20
Both routes Both routes found this disease 10.0 of 10
Species 0 naturally occurring species entries marked as a defect. 1 genetically engineered entry is not counted 0.0 of 10

Species

The chain follows only the species entries that OMIA marks as a defect.

Species Scientific name OMIA entry A defect
pig Genetically engineered, not naturally occurring. Not counted in the score. Sus scrofa OMIA:002293-9823 Yes

Genes

Each gene OMIA records for a species entry, and the human gene it reaches through Ensembl's orthologs.

Species Animal gene Human gene Ortholog
pig PAH NCBI Gene 100521900 PAH Ensembl one to one

Human diseases

Two routes lead from an OMIA group to a Mondo human disease: OMIA's own Mondo link, and the group's OMIM numbers through Mondo's cross-references.

Mondo disease Name Found by
MONDO:0009861 phenylketonuria A rare inborn error of amino acid metabolism characterized by elevated blood phenylalanine and low levels or absence of phenylalanine hydroxylase enzyme. If not detected early or left untreated, the disorder manifests with mild to severe mental disability. Both routes

Target evidence

Each Open Targets association between one of the group's human genes and one of its human diseases, with its overall score and the score for each kind of evidence.

Human gene Human disease Score Evidence Kinds of evidence
PAH phenylketonuria 0.89 3,210 Genetic association 0.98 Known drug 0.95 Genetic literature 0.84 Affected pathway 0.61 Animal model 0.49 Literature 0.49

Drugs

A drug acts on PAH and has been tested for this disease.

Drug Acts on How Latest stage Tested for this disease
Sapropterin PAH activator Approved Approved for phenylketonuria

The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.